ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rapid Microbial Presence Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-0G17823
Home | Market Reports | Science
Global Rapid Microbial Presence Tests Market Research Report 2024
BUY CHAPTERS

Global Rapid Microbial Presence Tests Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0G17823
Report
October 2025
Pages:163
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Abbott Laboratories
BD
Danaher
Sartorius
Merck
Charles River Laboratories
3M
Metrohm AG
Lucideon
Bruker
Neogen
SUEZ Water Technologies
MCS Diagnostics (CertaBlue)
Rapid Micro Biosystems
bioMérieux
Siemens Healthcare
Orasure Technologies
Irie Corporation
SGS Ltd
Bio Rad Laboratories
Qiagen NV

Rapid Microbial Presence Tests Market

The global Rapid Microbial Presence Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Rapid Microbial Presence Tests are a test method used to quickly detect the presence of microorganisms in a sample. These tests usually use fast and simple methods, such as rapid culture, immunological methods, molecular biology methods, etc., which can provide results in a shorter time. Through these tests, microbial contamination in samples can be detected in a timely manner, helping to take necessary control and treatment measures to ensure the safety and quality of products.
Rapid microbial presence tests have a wide range of applications and can be used in production processes, before products are put on the market, and in health supervision inspections, helping companies maintain the sanitary quality of products, reduce risks, and protect consumer health.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Rapid Microbial Presence Tests leading manufacturers including Thermo Fisher Scientific, Abbott Laboratories, BD, Danaher, Sartorius, Merck, Charles River Laboratories, 3M, Metrohm, Lucideon, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Rapid Microbial Presence Tests market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Rapid Microbial Presence Tests Market Report

Report Metric Details
Report Name Rapid Microbial Presence Tests Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Abbott Laboratories, BD, Danaher, Sartorius, Merck, Charles River Laboratories, 3M, Metrohm, Lucideon, Bruker, Neogen, SUEZ Water Technologies, MCS Diagnostics (CertaBlue), Rapid Micro Biosystems, BioMérieux, Siemens Healthcare, Orasure Technologies, Irie Corporation, SGS, Bio-Rad Laboratories, QIAGEN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Rapid Microbial Presence Tests study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Rapid Microbial Presence Tests Market report?

Ans: The main players in the Rapid Microbial Presence Tests Market are Thermo Fisher Scientific, Abbott Laboratories, BD, Danaher, Sartorius, Merck, Charles River Laboratories, 3M, Metrohm, Lucideon, Bruker, Neogen, SUEZ Water Technologies, MCS Diagnostics (CertaBlue), Rapid Micro Biosystems, BioMérieux, Siemens Healthcare, Orasure Technologies, Irie Corporation, SGS, Bio-Rad Laboratories, QIAGEN

What are the Application segmentation covered in the Rapid Microbial Presence Tests Market report?

Ans: The Applications covered in the Rapid Microbial Presence Tests Market report are Hospital, Laboratory, Biopharmaceutical, Food and Drink, Others

What are the Type segmentation covered in the Rapid Microbial Presence Tests Market report?

Ans: The Types covered in the Rapid Microbial Presence Tests Market report are Based on Nucleic Acid, Based on Growth, Based on Antigen and Antibody, Flow Cytometry, Others

Recommended Reports

Microbial Detection Markets

Rapid Diagnostic Devices

Food & Industrial Rapid Testing

1 Study Coverage
1.1 Introduction to Rapid Microbial Presence Tests: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Rapid Microbial Presence Tests Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Based on Nucleic Acid
1.2.3 Based on Growth
1.2.4 Based on Antigen and Antibody
1.2.5 Flow Cytometry
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Rapid Microbial Presence Tests Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Biopharmaceutical
1.3.5 Food and Drink
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rapid Microbial Presence Tests Revenue Estimates and Forecasts 2020-2031
2.2 Global Rapid Microbial Presence Tests Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Rapid Microbial Presence Tests Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Rapid Microbial Presence Tests Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Based on Nucleic Acid Market Size by Players
3.3.2 Based on Growth Market Size by Players
3.3.3 Based on Antigen and Antibody Market Size by Players
3.3.4 Flow Cytometry Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Rapid Microbial Presence Tests Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Rapid Microbial Presence Tests Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Rapid Microbial Presence Tests Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Rapid Microbial Presence Tests Market Size by Type (2020-2031)
6.4 North America Rapid Microbial Presence Tests Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Rapid Microbial Presence Tests Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Rapid Microbial Presence Tests Market Size by Type (2020-2031)
7.4 Europe Rapid Microbial Presence Tests Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Rapid Microbial Presence Tests Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Rapid Microbial Presence Tests Market Size by Type (2020-2031)
8.4 Asia-Pacific Rapid Microbial Presence Tests Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Rapid Microbial Presence Tests Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Rapid Microbial Presence Tests Market Size by Type (2020-2031)
9.4 Central and South America Rapid Microbial Presence Tests Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Rapid Microbial Presence Tests Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Rapid Microbial Presence Tests Market Size by Type (2020-2031)
10.4 Middle East and Africa Rapid Microbial Presence Tests Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Rapid Microbial Presence Tests Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Rapid Microbial Presence Tests Product Features and Attributes
11.1.4 Thermo Fisher Scientific Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Rapid Microbial Presence Tests Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Rapid Microbial Presence Tests Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Rapid Microbial Presence Tests Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Rapid Microbial Presence Tests SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Rapid Microbial Presence Tests Product Features and Attributes
11.2.4 Abbott Laboratories Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Laboratories Rapid Microbial Presence Tests Revenue by Product in 2024
11.2.6 Abbott Laboratories Rapid Microbial Presence Tests Revenue by Application in 2024
11.2.7 Abbott Laboratories Rapid Microbial Presence Tests Revenue by Geographic Area in 2024
11.2.8 Abbott Laboratories Rapid Microbial Presence Tests SWOT Analysis
11.2.9 Abbott Laboratories Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Business Overview
11.3.3 BD Rapid Microbial Presence Tests Product Features and Attributes
11.3.4 BD Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.3.5 BD Rapid Microbial Presence Tests Revenue by Product in 2024
11.3.6 BD Rapid Microbial Presence Tests Revenue by Application in 2024
11.3.7 BD Rapid Microbial Presence Tests Revenue by Geographic Area in 2024
11.3.8 BD Rapid Microbial Presence Tests SWOT Analysis
11.3.9 BD Recent Developments
11.4 Danaher
11.4.1 Danaher Corporation Information
11.4.2 Danaher Business Overview
11.4.3 Danaher Rapid Microbial Presence Tests Product Features and Attributes
11.4.4 Danaher Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.4.5 Danaher Rapid Microbial Presence Tests Revenue by Product in 2024
11.4.6 Danaher Rapid Microbial Presence Tests Revenue by Application in 2024
11.4.7 Danaher Rapid Microbial Presence Tests Revenue by Geographic Area in 2024
11.4.8 Danaher Rapid Microbial Presence Tests SWOT Analysis
11.4.9 Danaher Recent Developments
11.5 Sartorius
11.5.1 Sartorius Corporation Information
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Rapid Microbial Presence Tests Product Features and Attributes
11.5.4 Sartorius Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.5.5 Sartorius Rapid Microbial Presence Tests Revenue by Product in 2024
11.5.6 Sartorius Rapid Microbial Presence Tests Revenue by Application in 2024
11.5.7 Sartorius Rapid Microbial Presence Tests Revenue by Geographic Area in 2024
11.5.8 Sartorius Rapid Microbial Presence Tests SWOT Analysis
11.5.9 Sartorius Recent Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Business Overview
11.6.3 Merck Rapid Microbial Presence Tests Product Features and Attributes
11.6.4 Merck Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.6.5 Merck Recent Developments
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Corporation Information
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Rapid Microbial Presence Tests Product Features and Attributes
11.7.4 Charles River Laboratories Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.7.5 Charles River Laboratories Recent Developments
11.8 3M
11.8.1 3M Corporation Information
11.8.2 3M Business Overview
11.8.3 3M Rapid Microbial Presence Tests Product Features and Attributes
11.8.4 3M Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.8.5 3M Recent Developments
11.9 Metrohm
11.9.1 Metrohm Corporation Information
11.9.2 Metrohm Business Overview
11.9.3 Metrohm Rapid Microbial Presence Tests Product Features and Attributes
11.9.4 Metrohm Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.9.5 Metrohm Recent Developments
11.10 Lucideon
11.10.1 Lucideon Corporation Information
11.10.2 Lucideon Business Overview
11.10.3 Lucideon Rapid Microbial Presence Tests Product Features and Attributes
11.10.4 Lucideon Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Bruker
11.11.1 Bruker Corporation Information
11.11.2 Bruker Business Overview
11.11.3 Bruker Rapid Microbial Presence Tests Product Features and Attributes
11.11.4 Bruker Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.11.5 Bruker Recent Developments
11.12 Neogen
11.12.1 Neogen Corporation Information
11.12.2 Neogen Business Overview
11.12.3 Neogen Rapid Microbial Presence Tests Product Features and Attributes
11.12.4 Neogen Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.12.5 Neogen Recent Developments
11.13 SUEZ Water Technologies
11.13.1 SUEZ Water Technologies Corporation Information
11.13.2 SUEZ Water Technologies Business Overview
11.13.3 SUEZ Water Technologies Rapid Microbial Presence Tests Product Features and Attributes
11.13.4 SUEZ Water Technologies Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.13.5 SUEZ Water Technologies Recent Developments
11.14 MCS Diagnostics (CertaBlue)
11.14.1 MCS Diagnostics (CertaBlue) Corporation Information
11.14.2 MCS Diagnostics (CertaBlue) Business Overview
11.14.3 MCS Diagnostics (CertaBlue) Rapid Microbial Presence Tests Product Features and Attributes
11.14.4 MCS Diagnostics (CertaBlue) Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.14.5 MCS Diagnostics (CertaBlue) Recent Developments
11.15 Rapid Micro Biosystems
11.15.1 Rapid Micro Biosystems Corporation Information
11.15.2 Rapid Micro Biosystems Business Overview
11.15.3 Rapid Micro Biosystems Rapid Microbial Presence Tests Product Features and Attributes
11.15.4 Rapid Micro Biosystems Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.15.5 Rapid Micro Biosystems Recent Developments
11.16 BioMérieux
11.16.1 BioMérieux Corporation Information
11.16.2 BioMérieux Business Overview
11.16.3 BioMérieux Rapid Microbial Presence Tests Product Features and Attributes
11.16.4 BioMérieux Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.16.5 BioMérieux Recent Developments
11.17 Siemens Healthcare
11.17.1 Siemens Healthcare Corporation Information
11.17.2 Siemens Healthcare Business Overview
11.17.3 Siemens Healthcare Rapid Microbial Presence Tests Product Features and Attributes
11.17.4 Siemens Healthcare Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.17.5 Siemens Healthcare Recent Developments
11.18 Orasure Technologies
11.18.1 Orasure Technologies Corporation Information
11.18.2 Orasure Technologies Business Overview
11.18.3 Orasure Technologies Rapid Microbial Presence Tests Product Features and Attributes
11.18.4 Orasure Technologies Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.18.5 Orasure Technologies Recent Developments
11.19 Irie Corporation
11.19.1 Irie Corporation Corporation Information
11.19.2 Irie Corporation Business Overview
11.19.3 Irie Corporation Rapid Microbial Presence Tests Product Features and Attributes
11.19.4 Irie Corporation Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.19.5 Irie Corporation Recent Developments
11.20 SGS
11.20.1 SGS Corporation Information
11.20.2 SGS Business Overview
11.20.3 SGS Rapid Microbial Presence Tests Product Features and Attributes
11.20.4 SGS Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.20.5 SGS Recent Developments
11.21 Bio-Rad Laboratories
11.21.1 Bio-Rad Laboratories Corporation Information
11.21.2 Bio-Rad Laboratories Business Overview
11.21.3 Bio-Rad Laboratories Rapid Microbial Presence Tests Product Features and Attributes
11.21.4 Bio-Rad Laboratories Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.21.5 Bio-Rad Laboratories Recent Developments
11.22 QIAGEN
11.22.1 QIAGEN Corporation Information
11.22.2 QIAGEN Business Overview
11.22.3 QIAGEN Rapid Microbial Presence Tests Product Features and Attributes
11.22.4 QIAGEN Rapid Microbial Presence Tests Revenue and Gross Margin (2020-2025)
11.22.5 QIAGEN Recent Developments
12 Rapid Microbial Presence TestsIndustry Chain Analysis
12.1 Rapid Microbial Presence Tests Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Rapid Microbial Presence Tests Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Rapid Microbial Presence Tests Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Thermo Fisher Scientific
Abbott Laboratories
BD
Danaher
Sartorius
Merck
Charles River Laboratories
3M
Metrohm AG
Lucideon
Bruker
Neogen
SUEZ Water Technologies
MCS Diagnostics (CertaBlue)
Rapid Micro Biosystems
bioMérieux
Siemens Healthcare
Orasure Technologies
Irie Corporation
SGS Ltd
Bio Rad Laboratories
Qiagen NV
List of Tables
 Table 1. Global Rapid Microbial Presence Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Rapid Microbial Presence Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Rapid Microbial Presence Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Rapid Microbial Presence Tests Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Rapid Microbial Presence Tests Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Rapid Microbial Presence Tests Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Rapid Microbial Presence Tests Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Rapid Microbial Presence Tests by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Microbial Presence Tests as of 2024)
 Table 11. Global Rapid Microbial Presence Tests Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Rapid Microbial Presence Tests Companies Headquarters
 Table 13. Global Rapid Microbial Presence Tests Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Rapid Microbial Presence Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Rapid Microbial Presence Tests Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Rapid Microbial Presence Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Rapid Microbial Presence Tests Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Rapid Microbial Presence Tests High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Rapid Microbial Presence Tests Growth Accelerators and Market Barriers
 Table 25. North America Rapid Microbial Presence Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Rapid Microbial Presence Tests Growth Accelerators and Market Barriers
 Table 27. Europe Rapid Microbial Presence Tests Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Rapid Microbial Presence Tests Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Rapid Microbial Presence Tests Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Rapid Microbial Presence Tests Investment Opportunities and Key Challenges
 Table 31. Central and South America Rapid Microbial Presence Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Rapid Microbial Presence Tests Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Rapid Microbial Presence Tests Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Thermo Fisher Scientific Corporation Information
 Table 35. Thermo Fisher Scientific Description and Major Businesses
 Table 36. Thermo Fisher Scientific Product Features and Attributes
 Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 41. Thermo Fisher Scientific Rapid Microbial Presence Tests SWOT Analysis
 Table 42. Thermo Fisher Scientific Recent Developments
 Table 43. Abbott Laboratories Corporation Information
 Table 44. Abbott Laboratories Description and Major Businesses
 Table 45. Abbott Laboratories Product Features and Attributes
 Table 46. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Abbott Laboratories Revenue Proportion by Product in 2024
 Table 48. Abbott Laboratories Revenue Proportion by Application in 2024
 Table 49. Abbott Laboratories Revenue Proportion by Geographic Area in 2024
 Table 50. Abbott Laboratories Rapid Microbial Presence Tests SWOT Analysis
 Table 51. Abbott Laboratories Recent Developments
 Table 52. BD Corporation Information
 Table 53. BD Description and Major Businesses
 Table 54. BD Product Features and Attributes
 Table 55. BD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. BD Revenue Proportion by Product in 2024
 Table 57. BD Revenue Proportion by Application in 2024
 Table 58. BD Revenue Proportion by Geographic Area in 2024
 Table 59. BD Rapid Microbial Presence Tests SWOT Analysis
 Table 60. BD Recent Developments
 Table 61. Danaher Corporation Information
 Table 62. Danaher Description and Major Businesses
 Table 63. Danaher Product Features and Attributes
 Table 64. Danaher Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Danaher Revenue Proportion by Product in 2024
 Table 66. Danaher Revenue Proportion by Application in 2024
 Table 67. Danaher Revenue Proportion by Geographic Area in 2024
 Table 68. Danaher Rapid Microbial Presence Tests SWOT Analysis
 Table 69. Danaher Recent Developments
 Table 70. Sartorius Corporation Information
 Table 71. Sartorius Description and Major Businesses
 Table 72. Sartorius Product Features and Attributes
 Table 73. Sartorius Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Sartorius Revenue Proportion by Product in 2024
 Table 75. Sartorius Revenue Proportion by Application in 2024
 Table 76. Sartorius Revenue Proportion by Geographic Area in 2024
 Table 77. Sartorius Rapid Microbial Presence Tests SWOT Analysis
 Table 78. Sartorius Recent Developments
 Table 79. Merck Corporation Information
 Table 80. Merck Description and Major Businesses
 Table 81. Merck Product Features and Attributes
 Table 82. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Merck Recent Developments
 Table 84. Charles River Laboratories Corporation Information
 Table 85. Charles River Laboratories Description and Major Businesses
 Table 86. Charles River Laboratories Product Features and Attributes
 Table 87. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Charles River Laboratories Recent Developments
 Table 89. 3M Corporation Information
 Table 90. 3M Description and Major Businesses
 Table 91. 3M Product Features and Attributes
 Table 92. 3M Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. 3M Recent Developments
 Table 94. Metrohm Corporation Information
 Table 95. Metrohm Description and Major Businesses
 Table 96. Metrohm Product Features and Attributes
 Table 97. Metrohm Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Metrohm Recent Developments
 Table 99. Lucideon Corporation Information
 Table 100. Lucideon Description and Major Businesses
 Table 101. Lucideon Product Features and Attributes
 Table 102. Lucideon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Lucideon Recent Developments
 Table 104. Bruker Corporation Information
 Table 105. Bruker Description and Major Businesses
 Table 106. Bruker Product Features and Attributes
 Table 107. Bruker Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Bruker Recent Developments
 Table 109. Neogen Corporation Information
 Table 110. Neogen Description and Major Businesses
 Table 111. Neogen Product Features and Attributes
 Table 112. Neogen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Neogen Recent Developments
 Table 114. SUEZ Water Technologies Corporation Information
 Table 115. SUEZ Water Technologies Description and Major Businesses
 Table 116. SUEZ Water Technologies Product Features and Attributes
 Table 117. SUEZ Water Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. SUEZ Water Technologies Recent Developments
 Table 119. MCS Diagnostics (CertaBlue) Corporation Information
 Table 120. MCS Diagnostics (CertaBlue) Description and Major Businesses
 Table 121. MCS Diagnostics (CertaBlue) Product Features and Attributes
 Table 122. MCS Diagnostics (CertaBlue) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. MCS Diagnostics (CertaBlue) Recent Developments
 Table 124. Rapid Micro Biosystems Corporation Information
 Table 125. Rapid Micro Biosystems Description and Major Businesses
 Table 126. Rapid Micro Biosystems Product Features and Attributes
 Table 127. Rapid Micro Biosystems Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Rapid Micro Biosystems Recent Developments
 Table 129. BioMérieux Corporation Information
 Table 130. BioMérieux Description and Major Businesses
 Table 131. BioMérieux Product Features and Attributes
 Table 132. BioMérieux Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. BioMérieux Recent Developments
 Table 134. Siemens Healthcare Corporation Information
 Table 135. Siemens Healthcare Description and Major Businesses
 Table 136. Siemens Healthcare Product Features and Attributes
 Table 137. Siemens Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Siemens Healthcare Recent Developments
 Table 139. Orasure Technologies Corporation Information
 Table 140. Orasure Technologies Description and Major Businesses
 Table 141. Orasure Technologies Product Features and Attributes
 Table 142. Orasure Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Orasure Technologies Recent Developments
 Table 144. Irie Corporation Corporation Information
 Table 145. Irie Corporation Description and Major Businesses
 Table 146. Irie Corporation Product Features and Attributes
 Table 147. Irie Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Irie Corporation Recent Developments
 Table 149. SGS Corporation Information
 Table 150. SGS Description and Major Businesses
 Table 151. SGS Product Features and Attributes
 Table 152. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. SGS Recent Developments
 Table 154. Bio-Rad Laboratories Corporation Information
 Table 155. Bio-Rad Laboratories Description and Major Businesses
 Table 156. Bio-Rad Laboratories Product Features and Attributes
 Table 157. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Bio-Rad Laboratories Recent Developments
 Table 159. QIAGEN Corporation Information
 Table 160. QIAGEN Description and Major Businesses
 Table 161. QIAGEN Product Features and Attributes
 Table 162. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. QIAGEN Recent Developments
 Table 164. Raw Materials Key Suppliers
 Table 165. Distributors List
 Table 166. Market Trends and Market Evolution
 Table 167. Market Drivers and Opportunities
 Table 168. Market Challenges, Risks, and Restraints
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources


List of Figures
 Figure 1. Rapid Microbial Presence Tests Product Picture
 Figure 2. Global Rapid Microbial Presence Tests Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Based on Nucleic Acid Product Picture
 Figure 4. Based on Growth Product Picture
 Figure 5. Based on Antigen and Antibody Product Picture
 Figure 6. Flow Cytometry Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Rapid Microbial Presence Tests Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Hospital
 Figure 10. Laboratory
 Figure 11. Biopharmaceutical
 Figure 12. Food and Drink
 Figure 13. Others
 Figure 14. Rapid Microbial Presence Tests Report Years Considered
 Figure 15. Global Rapid Microbial Presence Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 17. Global Rapid Microbial Presence Tests Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 18. Global Rapid Microbial Presence Tests Revenue Market Share by Region (2020-2031)
 Figure 19. Global Rapid Microbial Presence Tests Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Based on Nucleic Acid Revenue Market Share by Player in 2024
 Figure 22. Based on Growth Revenue Market Share by Player in 2024
 Figure 23. Based on Antigen and Antibody Revenue Market Share by Player in 2024
 Figure 24. Flow Cytometry Revenue Market Share by Player in 2024
 Figure 25. Others Revenue Market Share by Player in 2024
 Figure 26. Global Rapid Microbial Presence Tests Revenue Market Share by Type (2020-2031)
 Figure 27. Global Rapid Microbial Presence Tests Revenue Market Share by Application (2020-2031)
 Figure 28. North America Rapid Microbial Presence Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Players Rapid Microbial Presence Tests Revenue (US$ Million) in 2024
 Figure 30. North America Rapid Microbial Presence Tests Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Rapid Microbial Presence Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Rapid Microbial Presence Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Europe Top 5 Players Rapid Microbial Presence Tests Revenue (US$ Million) in 2024
 Figure 37. Europe Rapid Microbial Presence Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Europe Rapid Microbial Presence Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Germany Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 40. France Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 41. U.K. Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 42. Italy Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 43. Russia Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Rapid Microbial Presence Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 45. Asia-Pacific Top 8 Players Rapid Microbial Presence Tests Revenue (US$ Million) in 2024
 Figure 46. Asia-Pacific Rapid Microbial Presence Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 47. Asia-Pacific Rapid Microbial Presence Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Indonesia Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 49. Japan Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 50. South Korea Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 51. Australia Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 52. India Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 53. Indonesia Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 54. Vietnam Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 55. Malaysia Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 56. Philippines Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 57. Singapore Rapid Microbial Presence Tests Revenue (2020-2031) & (US$ Million)
 Figure 58. Central and South America Rapid Microbial Presence Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Central and South America Top 5 Players Rapid Microbial Presence Tests Revenue (US$ Million) in 2024
 Figure 60. Central and South America Rapid Microbial Presence Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Central and South America Rapid Microbial Presence Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 62. Brazil Rapid Microbial Presence Tests Revenue (2020-2025) & (US$ Million)
 Figure 63. Argentina Rapid Microbial Presence Tests Revenue (2020-2025) & (US$ Million)
 Figure 64. Middle East and Africa Rapid Microbial Presence Tests Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Middle East and Africa Top 5 Players Rapid Microbial Presence Tests Revenue (US$ Million) in 2024
 Figure 66. South America Rapid Microbial Presence Tests Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Middle East and Africa Rapid Microbial Presence Tests Revenue (US$ Million) by Application (2020-2031)
 Figure 68. GCC Countries Rapid Microbial Presence Tests Revenue (2020-2025) & (US$ Million)
 Figure 69. Israel Rapid Microbial Presence Tests Revenue (2020-2025) & (US$ Million)
 Figure 70. Egypt Rapid Microbial Presence Tests Revenue (2020-2025) & (US$ Million)
 Figure 71. South Africa Rapid Microbial Presence Tests Revenue (2020-2025) & (US$ Million)
 Figure 72. Rapid Microbial Presence Tests Industry Chain Mapping
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Microbial Rapid Detection System Market Research Report 2025
Global Rapid Microbiological Burden Testing Market Research Report 2024
Global Pharmaceutical Microbiology Rapid Testing Market Research Report 2024
Global Rapid Microbiological Testing Equipment and Reagents Market Research Report 2024
Global Automated and Rapid Microbiological Tests Bussiness Market Research Report 2024
Global Rapid Microbiological Burden Detection Market Research Report 2024
Global Pharmaceutical Rapid Microbiology Testing Market Insights Forecast to 2030
Global Rapid Food Pathogen Testing Market Research Report 2024
Microbiological Test Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Detection System Market Insights Forecast to 2030
Global Rapid Testing for Respiratory Pathogens Market Research Report 2024
Global Microbial Test Kits Market Research Report 2024
Global Microbial Detection Analyzers Market Insights Forecast to 2030
Global Fast Biological Reader Market Research Report 2024
Global Microbial Detection Device Market Insights Forecast to 2030
Global Food Safety Rapid Testing System Market Research Report 2024
Global Microbial Detection Instrument Market Insights Forecast to 2030
Global Microbial Testing Market Research Report 2024
Global Microbial Detection Equipment Market Insights Forecast to 2030
Global Microbial Testing Service Market Research Report 2024

RELATED REPORTS

Global Sensors for Humanoid Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34E19768
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Magnetic Electrode Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2C20273
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Geiger Radiation Detector Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35E19945
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Laboratory Refrigerated Centrifuge Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21O7910
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions